Copeland Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Copeland Capital Management’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,454	Closed	-$877K	–	187
2015 Q3	$877K	Sell	12,454 -178,150	-93%	-$14.7M	0.05%	126
2015 Q2	$17.2M	Sell	190,604 -14,849	-7%	-$1.43M	0.88%	46
2015 Q1	$20.7M	Buy	205,453 +8,486	+4%	+$856K	1.37%	21
2014 Q4	$19.8M	Buy	196,967 +14,052	+8%	+$1.4M	1.44%	23
2014 Q3	$17.6M	Buy	182,915 +38,839	+27%	+$3.68M	1.79%	25
2014 Q2	$13.4M	Buy	144,076 +18,604	+15%	+$1.63M	1.5%	43
2014 Q1	$10.4M	Buy	125,472 +33,111	+36%	+$2.68M	1.27%	47
2013 Q4	$7.74M	Buy	+92,361	New	+$7.52M	1.01%	49

Other funds holding MJN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Copeland Capital Management's MJN Position: Q4 2015 in Review

Copeland Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q4 2015, closing a stake of 12,454 shares — an estimated $877K sold.

Copeland Capital Management first reported a position in MJN in Q4 2013 and held it in 8 quarters. The position peaked at $20.7M in Q1 2015. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

Copeland Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q4 2015 after selling out during the quarter.
Copeland Capital Management sold 12,454 Mead Johnson Nutrition Company shares in Q4 2015, an estimated $877K.
Copeland Capital Management first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 8 quarters.
Copeland Capital Management's Mead Johnson Nutrition Company position peaked at $20.7M in Q1 2015.
549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on Copeland Capital Management's 13F filing for Q4 2015, filed 4 Feb 2016.